Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia
- PMID: 17298164
- PMCID: PMC1796905
- DOI: 10.1371/journal.pmed.0040037
Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia
Abstract
Background: Defaulting from treatment remains a challenge for most tuberculosis control programmes. It may increase the risk of drug resistance, relapse, death, and prolonged infectiousness. The aim of this study was to determine factors predicting treatment adherence among smear-positive pulmonary tuberculosis patients.
Methods and findings: A cohort of smear-positive tuberculosis patients diagnosed and registered in Hossana Hospital in southern Ethiopia from 1 September 2002 to 30 April 2004 were prospectively included. Using a structured questionnaire, potential predictor factors for defaulting from treatment were recorded at the beginning of treatment, and patients were followed up until the end of treatment. Default incidence rate was calculated and compared among preregistered risk factors. Of the 404 patients registered for treatment, 81 (20%) defaulted from treatment. A total of 91% (74 of 81) of treatment interruptions occurred during the continuation phase of treatment. On a Cox regression model, distance from home to treatment centre (hazard ratio [HR] = 2.97; p < 0.001), age > 25 y (HR = 1.71; p = 0.02), and necessity to use public transport to get to a treatment centre (HR = 1.59; p = 0.06) were found to be independently associated with defaulting from treatment.
Conclusions: Defaulting due to treatment noncompletion in this study setting is high, and the main determinants appear to be factors related to physical access to a treatment centre. The continuation phase of treatment is the most crucial time for treatment interruption, and future interventions should take this factor into consideration.
Conflict of interest statement
Figures
Comment in
-
Adherence to TB treatment in Ethiopia: why do patients default?PLoS Med. 2007 Apr;4(4):e165. doi: 10.1371/journal.pmed.0040165. PLoS Med. 2007. PMID: 17456000 Free PMC article. No abstract available.
References
-
- Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10–15. - PubMed
-
- Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis. 1998;2:372–377. - PubMed
-
- Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, et al. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111:1168–1173. - PubMed
-
- Thomas C. A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med. 2002;16:371–400. - PubMed
-
- Kassim S, Sassam-Morokro M, Akhan A, Abouya LY, Digbeu H, et al. Two-year follow-up of persons with HIV-1 and HIV-2-associated pulmonary tuberculosis treated with short-course in West Africa. AIDS. 1995;9:1185–1191. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous